Wednesday 28 May, 2025 01:46 AM
Site map | Locate Us | Login
   Jio Financial ends higher after SEBI grants registration certificate to Jio BlackRock Mutual Fund    Rane (Madras) posts over 39% YoY drop in Q4 PAT to Rs 6.5 crore    HBL Engineering bags LoA for Kavach projects worth Rs 101 crore    Maharashtra Seamless records PAT of Rs 242 crore; EBIDTA margin at 20%    Dynamic Cables gains as board to consider bonus issue on 30 May    Sagility India drops as promoter launches OFS    Shilpa Medicare slides after Q4 PAT drop 41% YoY to Rs 15-cr    Shriram Properties sizzles after Q4 PAT zooms 137% to Rs 48 cr    Schneider Electric rallies after strong Q4 outcome    Rategain Travel Technologies Ltd leads losers in 'A' group    India Pesticides surges after reporting strong Q4 results    Ashapuri Gold Ornament Ltd leads losers in 'B' group    Bondada Engg gains on bagging Rs 204-cr LoA from TGGENCO    Volumes soar at Bayer CropScience Ltd counter    FMCG shares fall 
Saravan Stocks
       
Hot Pursuit
Scrips, which has significant changes during the market hours.
Dr Reddys Labs' manufacturing facility gets two form 483 observations from US FDA
26-May-25   09:33 Hrs IST

In a regulatory filing made on Saturday (24 May 2025), the company informed that the US FDA had conducted a GMP inspection at its API manufacturing facility in Miryalaguda, Telangana, India. The inspection was conducted from 19 May 2025 to 24 May 2025.

Post the inspection, the American regulatory agency has issued a Form 483 with 2 observations.

The pharmaceutical company stated that it would address the said observation from the US FDA within the stipulated timeline.

Hyderabad-based Dr. Reddy's Laboratories is a global pharmaceutical company. It offers a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC.

The company reported a consolidated net profit of Rs 1,594 crore for the quarter ended March 2025 (Q4FY25), marking a 22% year-on-year increase from Rs 1,307 crore in the same period last year. Revenue from operations rose 20% year-on-year to Rs 8,506 crore, compared to Rs 7,083 crore in Q4FY24.

The scrip rose 0.46% to currently trade at Rs 1235.40 on the BSE.

Powered by Capital Market - Live News
   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Investor Charter | Annual Return | Account Closure | RE-KYC | Disclaimer | Feed Back | Privacy Policy | Policies & Procedures | |Rights & Obligations-English| Rights & Obligations-தமிழ் | Anti Money Laundering Policy | E-Voting | CSR | Voluntary Freezing / Blocking | Policy GTC Hit Count : 41151402
Useful Links : NSE | BSE | MCX | NSDL | CDSL | SEBI | RBI | ATTENTION INVESTOR| SMART ODR
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL Securities Private Limited